<?xml version='1.0' encoding='utf-8'?>
<document id="32106230"><sentence text="A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction." /><sentence text="In vitro studies of drug toxicity and drug-drug interactions are crucial for drug development efforts" /><sentence text=" Currently, the utilization of primary human hepatocytes (PHHs) is the de facto standard for this purpose, due to their functional xenobiotic response and drug metabolizing CYP450 enzyme metabolism" /><sentence text=" However, PHHs are scarce, expensive, require laborious maintenance, and exhibit lot-to-lot heterogeneity" /><sentence text=" Alternative human in vitro platforms include hepatic cell lines, which are easy to access and maintain, and induced pluripotent stem cell (iPSC) derived hepatocytes" /><sentence text=" In this study, we provide a direct comparison of drug induced CYP3A4 and PXR expression levels of PHHs, hepatic cell lines Huh7 and HepG2, and iPSC derived hepatocyte like cells" /><sentence text=" Confluently cultured Huh7s exhibited an improved CYP3A4 expression and were inducible by up to 4" /><sentence text="9-fold, and hepatocytes differentiated from human iPSCs displayed a 3" /><sentence text="3-fold CYP3A4 induction" /><sentence text=" In addition, an increase in PXR expression levels was observed in both hepatic cell lines and iPSC derived hepatocytes upon rifampicin treatment, whereas a reproducible increase in PXR expression was not achieved in PHHs"><entity charOffset="125-135" id="DDI-PubMed.32106230.s10.e0" text="rifampicin" /></sentence><sentence text=" Our results indicate that both hepatoma originated cell lines and iPSCs may provide alternative sources to primary hepatocytes, providing reliable and reproducible results for CYP3A4/PXR metabolism, upon in vitro maturation" /><sentence text=" This study may serve as a guide for the selection of suitable and feasible in vitro platforms for drug-drug interaction and toxicology studies" /><sentence text="" /></document>